These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes. Rodríguez Cruz PM; Palace J; Beeson D Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875 [TBL] [Abstract][Full Text] [Related]
7. Congenital myasthenic syndromes: where do we go from here? Ramdas S; Beeson D Neuromuscul Disord; 2021 Oct; 31(10):943-954. PubMed ID: 34736634 [TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic characterisation of a large Indian congenital myasthenic syndrome cohort. Polavarapu K; Sunitha B; Töpf A; Preethish-Kumar V; Thompson R; Vengalil S; Nashi S; Bardhan M; Sanka SB; Huddar A; Unnikrishnan G; Arunachal G; Girija MS; Porter A; Azuma Y; Lorenzoni PJ; Baskar D; Anjanappa RM; Keertipriya M; Padmanabh H; Harikrishna GV; Laurie S; Matalonga L; Horvath R; Nalini A; Lochmüller H Brain; 2024 Jan; 147(1):281-296. PubMed ID: 37721175 [TBL] [Abstract][Full Text] [Related]
9. Inherited disorders of the neuromuscular junction: an update. Rodríguez Cruz PM; Palace J; Beeson D J Neurol; 2014 Nov; 261(11):2234-43. PubMed ID: 25305004 [TBL] [Abstract][Full Text] [Related]
10. Congenital myasthenic syndrome: a brief review. Lorenzoni PJ; Scola RH; Kay CS; Werneck LC Pediatr Neurol; 2012 Mar; 46(3):141-8. PubMed ID: 22353287 [TBL] [Abstract][Full Text] [Related]
11. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations. Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514 [TBL] [Abstract][Full Text] [Related]
12. Clinical and research strategies for limb-girdle congenital myasthenic syndromes. O'Connor E; Töpf A; Zahedi RP; Spendiff S; Cox D; Roos A; Lochmüller H Ann N Y Acad Sci; 2018 Jan; 1412(1):102-112. PubMed ID: 29315608 [TBL] [Abstract][Full Text] [Related]
14. Myasthenic syndromes due to defects in COL13A1 and in the N-linked glycosylation pathway. Beeson D; Cossins J; Rodriguez Cruz PM; Maxwell S; Liu WW; Palace J Ann N Y Acad Sci; 2018 Feb; 1413(1):163-169. PubMed ID: 29363764 [TBL] [Abstract][Full Text] [Related]
15. Genetic basis and phenotypic features of congenital myasthenic syndromes. Engel AG Handb Clin Neurol; 2018; 148():565-589. PubMed ID: 29478601 [TBL] [Abstract][Full Text] [Related]
19. Current status of the congenital myasthenic syndromes. Engel AG Neuromuscul Disord; 2012 Feb; 22(2):99-111. PubMed ID: 22104196 [TBL] [Abstract][Full Text] [Related]
20. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain. Logan CV; Cossins J; Rodríguez Cruz PM; Parry DA; Maxwell S; Martínez-Martínez P; Riepsaame J; Abdelhamed ZA; Lake AV; Moran M; Robb S; Chow G; Sewry C; Hopkins PM; Sheridan E; Jayawant S; Palace J; Johnson CA; Beeson D Am J Hum Genet; 2015 Dec; 97(6):878-85. PubMed ID: 26626625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]